Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

Similar articles for PubMed (Select 23131891)

1.

Hypomania associated with adjunctive aripiprazole in an elder female with recurrent major depressive disorder: dose-related phenomenon?

Lin HY, Lin CC, Liu CC.

J Clin Psychopharmacol. 2012 Dec;32(6):836-7. doi: 10.1097/JCP.0b013e318272d2b7. No abstract available.

PMID:
23131891
2.

An aripiprazole discontinuation syndrome.

Philip NS.

R I Med J (2013). 2013 Feb;96(2):13-4.

PMID:
24933746
3.

Hypomania associated with adjunctive low-dose aripiprazole: two case reports and a brief review of the literature.

Albert U, De Cori D, Bogetto F, Maina G.

Psychiatr Danub. 2014 Mar;26(1):80-3. No abstract available.

4.

Aripiprazole augmentation for treatment of patients with chronic or recurrent major depressive disorder: a 12-week prospective open-label multicentre study.

Pae CU, Jeon HJ, Lee BC, Seo HJ, Kim SG, Park EJ, Kim W, Kwak KP, Han C, Cho SJ, Hahn SW, Jon DI, Choi JH, Jun TY.

Int Clin Psychopharmacol. 2013 Nov;28(6):322-9. doi: 10.1097/YIC.0b013e3283643728.

PMID:
23873293
5.

Dosing patterns of aripiprazole and quetiapine for adjunctive treatment of major depressive disorder (2006-2010).

Jing Y, Guo Z, Kalsekar I, Forbes RA, Hebden T, Thase ME.

Int Clin Psychopharmacol. 2013 Mar;28(2):87-90. doi: 10.1097/YIC.0b013e32835ce232.

PMID:
23262644
6.

Cost-effectiveness of adjunctive therapy with atypical antipsychotics for acute treatment of major depressive disorder.

Taneja C, Papakostas GI, Jing Y, Baker RA, Forbes RA, Oster G.

Ann Pharmacother. 2012 May;46(5):642-9. doi: 10.1345/aph.1Q326. Epub 2012 May 1.

PMID:
22550279
7.

Efficacy of adjunctive aripiprazole in patients with major depressive disorder who showed minimal response to initial antidepressant therapy.

Nelson JC, Thase ME, Bellocchio EE, Rollin LM, Eudicone JM, McQuade RD, Marcus RN, Berman RM, Baker RA.

Int Clin Psychopharmacol. 2012 May;27(3):125-33. doi: 10.1097/YIC.0b013e3283502791.

PMID:
22466058
8.

Aripiprazole in bipolar depression: a pooled, post-hoc analysis by severity of core depressive symptoms.

Thase ME, Bowden CL, Nashat M, Eudicone JM, Marcus R, McQuade RD, Carlson BX.

Int J Psychiatry Clin Pract. 2012 Jun;16(2):121-31. doi: 10.3109/13651501.2011.632680. Epub 2012 Feb 1.

PMID:
22296512
9.

A double-blind, placebo-controlled study of aripiprazole adjunctive to antidepressant therapy among depressed outpatients with inadequate response to prior antidepressant therapy (ADAPT-A Study).

Fava M, Mischoulon D, Iosifescu D, Witte J, Pencina M, Flynn M, Harper L, Levy M, Rickels K, Pollack M.

Psychother Psychosom. 2012;81(2):87-97. doi: 10.1159/000332050. Epub 2012 Jan 25. Erratum in: Psychother Psychosom. 2012;81(4):261.

PMID:
22286203
10.

The effectiveness and safety of adjunctive aripiprazole in Taiwanese patients with antidepressant-refractory major depressive disorder: a prospective, open-label trial.

Chen SJ, Hsiao YL, Shen TW, Chen ST.

J Clin Psychopharmacol. 2012 Feb;32(1):56-60. doi: 10.1097/JCP.0b013e31823f6c7f.

PMID:
22198444
11.

Aripiprazole: a review of its use in the management of mania in adults with bipolar I disorder.

Dhillon S.

Drugs. 2012 Jan 1;72(1):133-62. doi: 10.2165/11208320-000000000-00000. Review.

PMID:
22191800
12.

Aripiprazole plus divalproex for recently manic or mixed patients with bipolar I disorder: a 6-month, randomized, placebo-controlled, double-blind maintenance trial.

Woo YS, Bahk WM, Chung MY, Kim DH, Yoon BH, Lee JH, Ahn YM, Chung SK, Kim JG, Lee KH, Paik KC.

Hum Psychopharmacol. 2011 Dec;26(8):543-53. doi: 10.1002/hup.1240. Epub 2011 Dec 2.

PMID:
22134973
13.

Efficacy of dose increase among nonresponders to low-dose aripiprazole augmentation in patients with inadequate response to antidepressant treatment: a randomized, double-blind, placebo-controlled, efficacy trial.

Mischoulon D, Witte J, Levy M, Papakostas GI, Pet LR, Hsieh WH, Pencina MJ, Ward S, Pollack MH, Fava M.

J Clin Psychiatry. 2012 Mar;73(3):353-7. doi: 10.4088/JCP.10m06541. Epub 2011 Sep 20.

PMID:
21939613
14.

Adjunctive low-dose aripiprazole with standard-dose sertraline in treating fresh major depressive disorder: a randomized, double-blind, controlled study.

Lin CH, Lin SH, Jang FL.

J Clin Psychopharmacol. 2011 Oct;31(5):563-8. doi: 10.1097/JCP.0b013e31822bb0db.

PMID:
21869699
15.

Aripiprazole-associated leukopenia with coadministration of fluoxetine: a case report.

Huang LC, Chiang KT.

J Clin Psychopharmacol. 2011 Jun;31(3):376-7. doi: 10.1097/JCP.0b013e31821a105c. No abstract available.

PMID:
21532363
16.

Aripiprazole adjunctive to antidepressant therapy.

Marcus RM, Sanchez R, Frost M, McQuade RD.

Am J Psychiatry. 2011 Feb;168(2):211; author reply 211. doi: 10.1176/appi.ajp.2010.10101515. No abstract available.

PMID:
21297051
17.

Aripiprazole as adjunctive therapy for patients with major depressive disorder: overview and implications of clinical trial data.

Pae CU, Forbes A, Patkar AA.

CNS Drugs. 2011 Feb;25(2):109-27. doi: 10.2165/11538980-000000000-00000. Review.

PMID:
21254788
18.

Neurobiological bases and clinical aspects of the use of aripiprazole in treatment-resistant major depressive disorder.

Blier P, Blondeau C.

J Affect Disord. 2011 Jan;128 Suppl 1:S3-10. doi: 10.1016/S0165-0327(11)70003-9. Review.

PMID:
21220079
19.

A clinical review of aripiprazole in bipolar depression and maintenance therapy of bipolar disorder.

Yatham LN.

J Affect Disord. 2011 Jan;128 Suppl 1:S21-8. doi: 10.1016/S0165-0327(11)70005-2. Review.

PMID:
21220077
20.

Three cases of hypomania and one case of mania during aripiprazole treatment.

Viikki M, Valtonen HM, Leinonen E.

Pharmacopsychiatry. 2011 Mar;44(2):78-81. doi: 10.1055/s-0030-1268428. Epub 2010 Dec 14. No abstract available.

PMID:
21157696
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk